Risk factor
Considerable default risk
Profitability factor
Favourable analyst view
About
GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'expensive
Target Price
The average target price of 006280.KS is 205779 and suggests 58.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation